T-Cell-Replete HLA-Haploidentical Transplantation Using Post-Transplantation High-Dose Cyclophosphamide in High Risk and Advanced ALL: Feasibility and Early Outcome

被引：0
|
作者：
Zoellner, Anna-Katharina [1 ]
Fritsch, Susanne [1 ]
Prevalsek, Dusan [1 ]
Koehnke, Thomas [1 ]
Hubmann, Max [1 ]
Lippl, Stephanie [1 ]
Kruger, Stephan [1 ]
Hellmuth, Johannes [1 ]
Mumm, Friederike [1 ]
Ledderose, Georg [1 ]
Barlow, Sophie [1 ]
Subklewe, Marion [1 ]
Spiekermann, Karsten [1 ]
Hiddemann, Wolfgang [1 ]
Albert, Michael H. [2 ]
Schmid, Christoph [3 ]
Hausmann, Andreas [4 ]
Tischer, Johanna [1 ]
机构：
[1] Univ Munich, Hosp Munich Grosshadern, Dept Internal Med 3, Hematopoiet Stem Cell Transplantat, Munich, Germany
[2] Dr von Hauner Univ Childrens Hosp, Pediat Hematol Oncol, Munich, Germany
[3] Univ Munich, Klinikum Augsburg, Dept Hematol & Oncol, Munich, Germany
[4] Klinikum Munchen Schwabing, Dept Internal Med 1, Munich, Germany
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
547
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [21] T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
    Devillier, R.
    Bramanti, S.
    Fuerst, S.
    Sarina, B.
    El-Cheikh, J.
    Crocchiolo, R.
    Granata, A.
    Chabannon, C.
    Morabito, L.
    Harbi, S.
    Faucher, C.
    Santoro, A.
    Weiller, P-J
    Vey, N.
    Carlo-Stella, C.
    Castagna, L.
    Blaise, D.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 194 - 198
  • [22] T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
    R Devillier
    S Bramanti
    S Fürst
    B Sarina
    J El-Cheikh
    R Crocchiolo
    A Granata
    C Chabannon
    L Morabito
    S Harbi
    C Faucher
    A Santoro
    P-J Weiller
    N Vey
    C Carlo-Stella
    L Castagna
    D Blaise
    [J]. Bone Marrow Transplantation, 2016, 51 : 194 - 198
  • [23] T CELL REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR REFRACTORY MULTIPLE MYELOMA USING NONMYELOABLATIVE CONDITIONING AND HIGH-DOSE POST TRANSPLANT CYCLOPHOSPHAMIDE
    Bramanti, S.
    Vai, A.
    El Cheikh, J.
    Furst, S.
    Crocchiolo, R.
    Sarina, B.
    Harbi, S.
    Granata, A.
    Mauro, E.
    Carlo-Stella, C.
    Santoro, A.
    Stoppa, A. M.
    Blaise, D.
    Castagna, L.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S352 - S352
  • [24] HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide in a child with sickle cell disease
    Wiebking, V.
    Schmid, I.
    Albert, M. H.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S444 - S445
  • [25] How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
    Chang, Ying-Jun
    Luznik, Leo
    Fuchs, Ephraim J.
    Huang, Xiao-Jun
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [26] Immune reconstitution after T-cell replete HLA haploidentical hematopoietic stem cell transplantation using high-dose post-transplant cyclophosphamide
    Maeda, Yoshinobu
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (01) : 1 - 9
  • [27] ST2 As a Biomarker of Non-Relapse Mortality after HLA-Haploidentical SCT with High-Dose Post-Transplantation Cyclophosphamide
    Solan, Laura
    Martinez-Laperche, Carolina
    Kwon, Mi
    Carbonell, Diego
    Balsalobre, Pascual
    Serrano, David
    Chicano, Maria
    Suarez-Gonzalez, Julia
    Anguita, Javier
    Gayoso, Jorge
    Buno, Ismael
    Diez-Martin, Jose L.
    [J]. BLOOD, 2017, 130
  • [28] Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis
    Ikegawa, Shuntaro
    Fujii, Nobuharu
    Tadokoro, Koh
    Sato, Kota
    Iwamoto, Miki
    Matsuda, Masayuki
    Inomata, Tomoko
    Sugiura, Hiroyuki
    Asano, Takeru
    Yoshida, Shohei
    Nishimori, Hisakazu
    Matsuoka, Ken-ichi
    Maeda, Yoshinobu
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (02)
  • [29] Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Fritsch, Susanne
    Haebe, Sarah
    Buecklein, Veit
    Schulz, Christoph
    Hubmann, Max
    Stemmler, Hans-Joachim
    Ledderose, Georg
    Hausmann, Andreas
    Schmid, Christoph
    Tischer, Johanna
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1524 - 1531
  • [30] IMPACT OF HLA DISPARITY ON OUTCOME IN HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION FOLLOWED BY HIGH DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Giannoni, L.
    Raiola, A. M.
    Sacchi, N.
    Garbarino, L.
    Dominietto, A.
    Varaldo, R.
    Bregante, S.
    Di Grazia, C.
    Aquino, S.
    Ibatici, A.
    Gualandi, F.
    Van Lint, M. T.
    Lamparelli, T.
    Risitano, A.
    Bacigalupo, A.
    Angelucci, E.
    [J]. HAEMATOLOGICA, 2017, 102 : 325 - 326
12345